Dosage of Amoxiclav Forte in details
Amoxiclav Forte-600, 600 mg/5 mL, does not contain the same amount of Clavulanic Acid (Amoxiclav Forte) (as the potassium salt) as any of the other suspensions of AUGMENTIN. Amoxiclav Forte-600 contains 42.9 mg of Clavulanic Acid (Amoxiclav Forte) per 5 mL, whereas the 200 mg/5 mL suspension of AUGMENTIN contains 28.5 mg of Clavulanic Acid (Amoxiclav Forte) per 5 mL and the 400 mg/5 mL suspension contains 57 mg of Clavulanic Acid (Amoxiclav Forte) per 5 mL. Therefore, the 200 mg/5 mL and 400 mg/5 mL suspensions of AUGMENTIN should not be substituted for Amoxiclav Forte-600, as they are not interchangeable.
Dosage
Pediatric patients 3 months and older: Based on the Amoxicillin (Amoxiclav Forte) component (600 mg/5 mL), the recommended dose of Amoxiclav Forte-600 is 90 mg/kg/day divided every 12 hours, administered for 10 days.
| Body Weight (kg) | Volume of Amoxiclav Forte-600 providing 90 mg/kg/day |
| 8 | 3.0 mL twice daily |
| 12 | 4.5 mL twice daily |
| 16 | 6.0 mL twice daily |
| 20 | 7.5 mL twice daily |
| 24 | 9.0 mL twice daily |
| 28 | 10.5 mL twice daily |
| 32 | 12.0 mL twice daily |
| 36 | 13.5 mL twice daily |
Pediatric patients weighing 40 kg and more: Experience with Amoxiclav Forte-600 (600 mg/5 mL formulation) in this group is not available.
Adults: Experience with Amoxiclav Forte-600 (600 mg/5 mL formulation) in adults is not available and adults who have difficulty swallowing should not be given Amoxiclav Forte-600 (600 mg/5 mL) in place of the 500-mg or 875-mg tablet of AUGMENTIN.
Hepatically impaired patients should be dosed with caution and hepatic function monitored at regular intervals.
Directions for Mixing
Oral Suspension
Prepare a suspension at time of dispensing as follows: Tap bottle until all the powder flows freely. Add approximately 2/3 of the total amount of water for reconstitution and shake vigorously to suspend powder. Add remainder of the water and again shake vigorously.
Amoxiclav Forte-600 (600 mg/5 mL Suspension)
| Bottle Size | Amount of Water Required for Reconstitution |
| 75 mL | 70 mL |
| 125 mL | 110 mL |
| 200 mL | 180 mL |
Each teaspoonful (5 mL) will contain 600 mg Amoxicillin (Amoxiclav Forte) as the trihydrate and 42.9 mg of Clavulanic Acid (Amoxiclav Forte) as the potassium salt.
NOTE: SHAKE ORAL SUSPENSION WELL BEFORE USING.
Information for the Pharmacist: For patients who wish to alter the taste of Amoxiclav Forte-600, immediately after reconstitution 1 drop of FLAVORx™ (apple, banana cream, bubble gum, cherry, or watermelon flavor) may be added for every 5 mL of Amoxiclav Forte-600. The resulting suspension is stable for 10 days under refrigeration. Other than the 5 flavors listed above, GlaxoSmithKline has not evaluated the stability of Amoxiclav Forte-600 when mixed with other flavors distributed by FLAVORx.
Administration: To minimize the potential for gastrointestinal intolerance, Amoxiclav Forte-600 should be taken at the start of a meal. Absorption of clavulanate potassium may be enhanced when Amoxiclav Forte-600 is administered at the start of a meal.
How supplied
Amoxiclav Forte-600, 600 mg/5 mL, for
Oral Suspension:
Each 5 mL of reconstituted strawberry cream-flavored suspension contains 600 mg Amoxicillin (Amoxiclav Forte) and 42.9 mg Clavulanic Acid (Amoxiclav Forte) as the potassium salt.NDC 43598-003-69
What other drugs will affect Amoxiclav Forte?
Tell your doctor about all other medications you use, especially:
- allopurinol (Zyloprim);
- probenecid (Benemid);
- a blood thinner such as warfarin (Coumadin, Jantoven); or
- another antibiotic (for the same or for a different infection).
This list is not complete and other drugs may interact with Amoxicillin (Amoxiclav Forte) and clavulanate potassium. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
Amoxiclav Forte interactions
Administration of probenecid prior to dosing results in marked increase in the mean serum concentrations of Amoxicillin (Amoxiclav Forte). Probenecid decreases the renal tubular secretion of Amoxicillin (Amoxiclav Forte), but does not affect Clavulanic Acid (Amoxiclav Forte) excretion. Concurrent use with Amoxiclav Forte may result in increased and prolonged blood levels of Amoxicillin (Amoxiclav Forte) but not of Clavulanic Acid (Amoxiclav Forte).
When Amoxicillin (Amoxiclav Forte) and warfarin are taken concomitantly, the INR can be altered.
Interaction of Amoxiclav Forte with coumarin or indandione-derivative anticoagulants, heparin, NSAIDs especially aspirin, other platelet aggregation inhibitors or thrombolytic agents may be clinically significant.
Amoxiclav Forte may decrease the efficacy of oestrogen-containing oral contraceptives. Patients should be warned accordingly. The simultaneous use of Amoxicillin (Amoxiclav Forte) and an oral contraceptive might be expected to cause breakthrough bleeding or pregnancy on rare occasions because of reduced absorption owing to diarrhea, on the basis of experience with ampicillin.
The concurrent administration of allopurinol and ampicillin substantially increases the incidence of rashes in patients receiving both agents as compared to patients receiving ampicillin alone. It is not known whether this potentiation of ampicillin rashes is due to allopurinol or the hyperuricaemia present in these patients. There are no data on Amoxicillin (Amoxiclav Forte)/clavulanate combination and allopurinol administered concurrently.
No information is available about the concurrent use of Amoxiclav Forte and alcohol. However, the ingestion of alcohol whilst being treated with some other β-lactam antibiotics has precipitated a disulfiram (Antabuse)-like reaction in some patients. Therefore, the ingestion of alcohol should be avoided during and for several days after treatment with Amoxiclav Forte.
Following administration of ampicillin to pregnant women, a transient decrease in plasma concentration of total conjugate oestriol, oestrio-glucuronide, conjugated oestrone and oestradiol has been noted. This effect may also occur with Amoxicillin (Amoxiclav Forte) and therefore, Amoxiclav Forte.
The use of this antibiotic may lead to the selection of resistant strains of organisms and sensitivity testing should, therefore, be carried out whenever possible, to demonstrate the appropriateness of therapy.
References
- DailyMed. "AMOXICILLIN; CLAVULANATE POTASSIUM: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- FDA/SPL Indexing Data. "9EM05410Q9: The UNique Ingredient Identifier (UNII) is an alphanumeric substance identifier from the joint FDA/USP Substance Registration System (SRS).". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Amoxiclav Forte are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Amoxiclav Forte. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported frequency of use
No survey data has been collected yetConsumer reported doses
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
